Dr. Sulaiman Al Habib Medical Services Group Company — Cyborg Score 8/10

Strong
Healthcare Services

Strategic Profile

The company establishes, manages, and operates hospitals, medical complexes, day surgery centers, pharmaceutical facilities, and provides home health care, medical laboratories, tele-medicine, and digital services including remote medical advice and E-Pharmacy services. The majority of revenue is earned from the Hospitals/Healthcare Facilities segment.

Cyborg Score Rationale

Leading regional healthcare operator with substantial market capitalization, diversified service portfolio spanning hospitals, pharmacies, and digital health solutions. Strong dividend yield and established brand presence across Middle East support solid market position.

Top Insights

  • Market cap of $25.4B as of June 2025 reflects leadership position in Middle East healthcare sector
  • Diversified revenue model across three segments with hospitals generating majority of revenue
  • Strong dividend yield of 1.76% indicates shareholder returns and financial stability
  • Multi-segment approach including pharmacies and HMG Solutions/Others provides revenue diversification and cross-selling opportunities

Named Competitors

  • Middle East Healthcare Company — Regional healthcare operator in Saudi Arabia

Recent Developments

  • (April 2022) Corporate partnership with Tamkeen HR for human resources services

Open the full interactive Dr. Sulaiman Al Habib Medical Services Group Company report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.

Open report →